Page last updated: 2024-11-10

methylserine phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3964633
CHEMBL ID1437137
SCHEMBL ID13184575
MeSH IDM0332406

Synonyms (20)

Synonym
gtpl1398
alpha-msop
alpha-methylserine-o-phosphate
msop
NCGC00024799-02
L000819
AKOS006275016
2-amino-2-methyl-3-phosphonooxypropanoic acid
(rs)-alpha-methylserine-o-phosphate
66515-29-5
SCHEMBL13184575
CHEMBL1437137
(rs)-?-methylserine-o-phosphate
DTXSID40398271
sr-01000597443
SR-01000597443-1
2-amino-2-methyl-3-(phosphonooxy)propanoic acid
Q27074406
CS-0021013
HY-101226
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency25.11890.141337.9142100.0000AID1490
regulator of G-protein signaling 4Homo sapiens (human)Potency0.53230.531815.435837.6858AID504845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1346263Human mGlu7 receptor (Metabotropic glutamate receptors)2000Naunyn-Schmiedeberg's archives of pharmacology, Dec, Volume: 362, Issue:6
Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes.
AID1346251Rat mGlu8 receptor (Metabotropic glutamate receptors)2002Current drug targets. CNS and neurological disorders, Jun, Volume: 1, Issue:3
The metabotropic glutamate receptors: structure, activation mechanism and pharmacology.
AID1346287Rat mGlu2 receptor (Metabotropic glutamate receptors)1998British journal of pharmacology, Feb, Volume: 123, Issue:3
Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
AID1346255Rat mGlu6 receptor (Metabotropic glutamate receptors)2002Current drug targets. CNS and neurological disorders, Jun, Volume: 1, Issue:3
The metabotropic glutamate receptors: structure, activation mechanism and pharmacology.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.94 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]